Literature DB >> 26313340

Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research.

Martin Pouliot1, Stephane Jeanmart1.   

Abstract

Every week, articles disclosing new antifungal leads reported as promising starting points for optimization projects are published. In many cases, the mechanism that accounts for their antifungal activity has not been fully elucidated. More significantly, the detrimental impact that could result from certain embedded chemical features has been underestimated or even overlooked. In the course of our research in the agrochemical area, we have concluded that in many cases such leads are actually nonoptimizable because they either contain what are now recognized as pan assay interference compounds (PAINS) or other promiscuous groups. This article is aimed at highlighting the pitfalls we have encountered and hopefully to steer other research groups away from them.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26313340     DOI: 10.1021/acs.jmedchem.5b00361

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  26 in total

1.  SAR Studies on Aromatic Acylhydrazone-Based Inhibitors of Fungal Sphingolipid Synthesis as Next-Generation Antifungal Agents.

Authors:  Krupanandan Haranahalli; Cristina Lazzarini; Yi Sun; Julia Zambito; Senuri Pathiranage; J Brian McCarthy; John Mallamo; Maurizio Del Poeta; Iwao Ojima
Journal:  J Med Chem       Date:  2019-08-16       Impact factor: 7.446

2.  Fluorescence polarization assays in high-throughput screening and drug discovery: a review.

Authors:  Matthew D Hall; Adam Yasgar; Tyler Peryea; John C Braisted; Ajit Jadhav; Anton Simeonov; Nathan P Coussens
Journal:  Methods Appl Fluoresc       Date:  2016-04-28       Impact factor: 3.009

3.  The Ecstasy and Agony of Assay Interference Compounds.

Authors:  Courtney Aldrich; Carolyn Bertozzi; Gunda I Georg; Laura Kiessling; Craig Lindsley; Dennis Liotta; Kenneth M Merz; Alanna Schepartz; Shaomeng Wang
Journal:  ACS Med Chem Lett       Date:  2017-02-28       Impact factor: 4.345

Review 4.  The antifungal pipeline: a reality check.

Authors:  John R Perfect
Journal:  Nat Rev Drug Discov       Date:  2017-05-12       Impact factor: 84.694

5.  In Silico Discovery of JMJD6 Inhibitors for Cancer Treatment.

Authors:  Ting Ran; Rongquan Xiao; Qixuan Huang; Haoliang Yuan; Tao Lu; Wen Liu
Journal:  ACS Med Chem Lett       Date:  2019-11-19       Impact factor: 4.345

6.  Elucidating the Catalytic Power of Glutamate Racemase by Investigating a Series of Covalent Inhibitors.

Authors:  Nicholas R Vance; Katie R Witkin; Patrick W Rooney; Yalan Li; Marshall Pope; M Ashley Spies
Journal:  ChemMedChem       Date:  2018-11-21       Impact factor: 3.466

7.  Inhibition of Both Hsp70 Activity and Tau Aggregation in Vitro Best Predicts Tau Lowering Activity of Small Molecules.

Authors:  Mackenzie D Martin; Jeremy D Baker; Amirthaa Suntharalingam; Bryce A Nordhues; Lindsey B Shelton; Dali Zheng; Jonathan J Sabbagh; Timothy A J Haystead; Jason E Gestwicki; Chad A Dickey
Journal:  ACS Chem Biol       Date:  2016-05-26       Impact factor: 5.100

Review 8.  Therapeutic Potential of Spirooxindoles as Antiviral Agents.

Authors:  Na Ye; Haiying Chen; Eric A Wold; Pei-Yong Shi; Jia Zhou
Journal:  ACS Infect Dis       Date:  2016-05-05       Impact factor: 5.084

Review 9.  Iron Acquisition Systems of Gram-negative Bacterial Pathogens Define TonB-Dependent Pathways to Novel Antibiotics.

Authors:  Phillip E Klebba; Salete M C Newton; David A Six; Ashish Kumar; Taihao Yang; Brittany L Nairn; Colton Munger; Somnath Chakravorty
Journal:  Chem Rev       Date:  2021-03-16       Impact factor: 60.622

10.  Discovery of a first-in-class inhibitor of sulfide:quinone oxidoreductase that protects against adverse cardiac remodelling and heart failure.

Authors:  Michael R Jackson; Kristie D Cox; Simon D P Baugh; Luke Wakeen; Adel A Rashad; Patrick Y S Lam; Boris Polyak; Marilyn Schuman Jorns
Journal:  Cardiovasc Res       Date:  2022-06-22       Impact factor: 13.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.